Figure 4
From: High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma
High expression of SOX30 is correlated with better OS in ADC patients at clinical stage II or with lymph node-positive.
(A) Kaplan-Meir survival analysis of SOX30 expression in 24 clinical stage II ADC patients. The patients with high SOX30 expression had a good OS rate; Low, staining weak and moderate; High, staining strong. (B) Cox regression survival analysis of SOX30 expression in 24 clinical stage II ADC patients. SOX30 expression was an independent prognostic factor. (C) Kaplan-Meir survival analysis of SOX30 in 68 ADC patients with lymph node-positive. The high SOX30 expression group had a good OS rate; Low, staining weak and moderate; High, staining strong. LN Positive, lymph node-positive. (D) Cox regression survival analysis of SOX30 expression in 68 ADC patients with lymph node-positive. SOX30 expression was an independent prognostic factor in these patients.
